Please click here for NHS advice on mild Covid-19.
PANORAMIC is a UK-wide clinical study to discover whether new antiviral treatments for COVID-19 in the community reduce the need for hospital admission, and reduce illness duration.
It is open to patients who:
✓ are currently experiencing COVID-19 symptoms which began in the last 5 days
✓ AND have had a positive PCR test for COVID-19 in the past 7 days
✓ AND are: ‒ Aged 50 or over,
‒ OR aged 18-49 with a pre-existing condition – full list available here:
- Note this study is not open to patients who are pregnant, or who require hospitalisation for COVID-19.
Patients who are referred to the PANORAMIC study have a 50% chance of receiving an antiviral treatment (molnupiravir).
As a practice we encourage and support eligible patients to enrol on the PANORAMIC study in one of two ways:
- Through signposting to online self-referral (click this link to join the study: https://www.panoramictrial.org/)
- Through referring into a local GP Research Hub.
GPs must not prescribe molnupiravir. Community pharmacies will not have access to any stocks of molnupiravir at this stage, and therefore patients will not be supplied with the medicine. Therefore eligible patients must access the PANORAMIC study through the methods outlined above.
Further info is available from https://www.panoramictrial.org/